AAAAAA

   
Results: 1-21 |
Results: 21
Long term anticoagulation or antiplatelet treatment - Giving warfarin always depends on balancing risks
Authors: Godtfredsen, J Boysen, G Petersen, P
Citation: J. Godtfredsen et al., Long term anticoagulation or antiplatelet treatment - Giving warfarin always depends on balancing risks, BR MED J, 323(7306), 2001, pp. 234-234
Tinzaparin in acute ischemic stroke (TAIST): a randomised aspirin-controlled trial.
Authors: Bath, PMW Lindenstrom, E Boysen, G De Deyn, P
Citation: Pmw. Bath et al., Tinzaparin in acute ischemic stroke (TAIST): a randomised aspirin-controlled trial., PRESSE MED, 30(32), 2001, pp. 1572-1573
Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study
Authors: Truelsen, T Prescott, E Lange, P Schnohr, P Boysen, G
Citation: T. Truelsen et al., Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study, INT J EPID, 30(1), 2001, pp. 145-151
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial
Authors: Bath, PMW Lindenstrom, E Boysen, G De Deyn, P Friis, P Leys, D Marttila, R Olsson, JE O'Neill, D Orgogozo, JM Ringelstein, B van der Sande, JJ Turpie, AGG
Citation: Pmw. Bath et al., Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial, LANCET, 358(9283), 2001, pp. 702-710
Hypertension in acute stroke: What to do?
Authors: Bath, P Boysen, G Donnan, G Kaste, M Lees, KR Olsen, T Overgaard, K Sandercock, P Wahlgren, NG
Citation: P. Bath et al., Hypertension in acute stroke: What to do?, STROKE, 32(7), 2001, pp. 1697-1698
Re: Stroke severity determines body temperature in acute stroke - Response
Authors: Boysen, G Christensen, H
Citation: G. Boysen et H. Christensen, Re: Stroke severity determines body temperature in acute stroke - Response, STROKE, 32(7), 2001, pp. 1697-1697
Stroke severity determines body temperature in acute stroke
Authors: Boysen, G Christensen, H
Citation: G. Boysen et H. Christensen, Stroke severity determines body temperature in acute stroke, STROKE, 32(2), 2001, pp. 413-417
Early stroke: A dynamic process
Authors: Boysen, G Christensen, H
Citation: G. Boysen et H. Christensen, Early stroke: A dynamic process, STROKE, 32(10), 2001, pp. 2423-2425
Prevention of recurrent stroke
Authors: Boysen, G Truelsen, T
Citation: G. Boysen et T. Truelsen, Prevention of recurrent stroke, NEUROL SCI, 21(2), 2000, pp. 67-72
Acute neurological stroke care in Europe: results of the European Stroke Care Inventory
Authors: Brainin, M Bornstein, N Boysen, G Demarin, V
Citation: M. Brainin et al., Acute neurological stroke care in Europe: results of the European Stroke Care Inventory, EUR J NEUR, 7(1), 2000, pp. 5-10
Tirilazad mesylate in acute ischemic stroke - A systematic review
Authors: Bath, PMW Blecic, S Bogousslavsky, J Boysen, G Davis, S Diez-Tejedor, E Ferro, JM Gommans, J Hacke, W Indredavik, B Norrving, B Orgogozo, JM Ringelstein, EB Sacchetti, ML Idddenden, R Bath, FJ Musch, BC Brosse, DM Naberhuis-Stehouwer, SA
Citation: Pmw. Bath et al., Tirilazad mesylate in acute ischemic stroke - A systematic review, STROKE, 31(9), 2000, pp. 2257-2265
The coordination of subordinate clauses in Middle French
Authors: Boysen, G
Citation: G. Boysen, The coordination of subordinate clauses in Middle French, REV ROMAN, 35(1), 2000, pp. 140-141
Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type)
Authors: Maury, CPJ Liljestrom, M Boysen, G Tornroth, T de la Chapelle, A Nurmiaho-Lassila, EL
Citation: Cpj. Maury et al., Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type), J CLIN PATH, 53(2), 2000, pp. 95-99
Prevention of recurrent stroke: risk of hemorrhage
Authors: Boysen, G
Citation: G. Boysen, Prevention of recurrent stroke: risk of hemorrhage, PREVENTION OF ISCHEMIC STROKE, 2000, pp. 147-156
Direct costs during the first year after intracerebral hemorrhage
Authors: Porsdal, V Boysen, G
Citation: V. Porsdal et G. Boysen, Direct costs during the first year after intracerebral hemorrhage, EUR J NEUR, 6(4), 1999, pp. 449-454
The value of stroke prophylaxis
Authors: Boysen, G Porsdal, V
Citation: G. Boysen et V. Porsdal, The value of stroke prophylaxis, EUR J NEUR, 6, 1999, pp. S25-S29
Bleeding complications in secondary stroke prevention by antiplatelet therapy: a benefit-risk analysis
Authors: Boysen, G
Citation: G. Boysen, Bleeding complications in secondary stroke prevention by antiplatelet therapy: a benefit-risk analysis, J INTERN M, 246(3), 1999, pp. 239-245
Costs of health care and social services during the first year after ischemic stroke
Authors: Porsdal, V Boysen, G
Citation: V. Porsdal et G. Boysen, Costs of health care and social services during the first year after ischemic stroke, INT J TE A, 15(3), 1999, pp. 573-584
Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model
Authors: Andersen, M Overgaard, K Meden, P Boysen, G
Citation: M. Andersen et al., Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model, STROKE, 30(7), 1999, pp. 1464-1470
Thrombolysis in acute ischemic stroke: Controlled trials and clinical experience
Authors: Hacke, W Brott, T Caplan, L Meier, D Fieschi, C von Kummer, R Donnan, G Heiss, WD Wahlgren, NG Spranger, M Boysen, G Marler, JR
Citation: W. Hacke et al., Thrombolysis in acute ischemic stroke: Controlled trials and clinical experience, NEUROLOGY, 53(7), 1999, pp. S3-S14
Warfarin vs aspirin and AFASAK 2 - Reply
Authors: Gullov, AL Koefoed, BG Petersen, P Pedersen, TS Andersen, ED Godtfredsen, J Boysen, G
Citation: Al. Gullov et al., Warfarin vs aspirin and AFASAK 2 - Reply, ARCH IN MED, 159(9), 1999, pp. 1010-1011
Risultati: 1-21 |